US Patent Issued to Selexs on Sept. 2 for "Characterization and inactivation of endogenous retroviruses in chinese hamster ovary cells" (Swiss Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,404,527, issued on Sept. 2, was assigned to Selexs S.A. (Plan-les-Ouates, Switzerland).

"Characterization and inactivation of endogenous retroviruses in chinese hamster ovary cells" was invented by Pierre-Olivier Duroy (Plan-les-Ouates, Switzerland), Sandra Bosshard (Plan-les-Ouates, Switzerland), Philippe Le Mercier (Plan-les-Ouates, Switzerland), Emanuel Schmid-Siegert (Plan-les-Ouates, Switzerland) and Nicolas Mermod (Plan-les-Ouates, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Type-C endogenous retroviruses (ERVs) embedded in Chinese hamster ovary (CHO) cells were altered to modify the release of retroviral and/or retroviral-like part...